{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:19:44Z","timestamp":1787314784543,"version":"build-2736575974"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T00:00:00Z","timestamp":1518825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s00259-018-3966-7","type":"journal-article","created":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T07:31:20Z","timestamp":1518852680000},"page":"677-679","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Combining baseline TMTV and gene profiling for a better risk stratification in diffuse large B cell lymphoma"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9207-0847","authenticated-orcid":false,"given":"Nicolas","family":"Aide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charline","family":"Lasnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gandhi","family":"Damaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,17]]},"reference":[{"key":"3966_CR1","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1200\/JCO.2009.26.2493","volume":"28","author":"M Ziepert","year":"2010","unstructured":"Ziepert M, Hasenclever D, Kuhnt E, Glass B, Schmitz N, Pfreundschuh M, et al. Standard international prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era. J Clin Oncol. 2010;28:2373\u201380. \n                    https:\/\/doi.org\/10.1200\/jco.2009.26.2493\n                    \n                  .","journal-title":"J Clin Oncol"},{"key":"3966_CR2","doi-asserted-by":"publisher","first-page":"5494","DOI":"10.1158\/1078-0432.CCR-09-0113","volume":"15","author":"WW Choi","year":"2009","unstructured":"Choi WW, Weisenburger DD, Greiner TC, Piris MA, Banham AH, Delabie J, et al. A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res. 2009;15:5494\u2013502. \n                    https:\/\/doi.org\/10.1158\/1078-0432.ccr-09-0113\n                    \n                  .","journal-title":"Clin Cancer Res"},{"key":"3966_CR3","doi-asserted-by":"publisher","first-page":"9991","DOI":"10.1073\/pnas.1732008100","volume":"100","author":"G Wright","year":"2003","unstructured":"Wright G, Tan B, Rosenwald A, Hurt EH, Wiestner A, Staudt LM. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci U S A. 2003;100:9991\u20136. \n                    https:\/\/doi.org\/10.1073\/pnas.1732008100\n                    \n                  .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3966_CR4","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1182\/blood-2013-11-536433","volume":"123","author":"DW Scott","year":"2014","unstructured":"Scott DW, Wright GW, Williams PM, Lih CJ, Walsh W, Jaffe ES, et al. Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue. Blood. 2014;123:1214\u20137. \n                    https:\/\/doi.org\/10.1182\/blood-2013-11-536433\n                    \n                  .","journal-title":"Blood"},{"key":"3966_CR5","doi-asserted-by":"publisher","unstructured":"Mareschal S, Ruminy P, Bagacean C, Marchand V, Cornic M, Jais JP, et al. Accurate classification of germinal Center B-cell-like\/activated B-cell-like diffuse large B-cell lymphoma using a simple and rapid reverse transcriptase-multiplex ligation-dependent probe amplification assay: a CALYM study. J Mo Diagn. 2015; \n                    https:\/\/doi.org\/10.1016\/j.jmoldx.2015.01.007\n                    \n                  .","DOI":"10.1016\/j.jmoldx.2015.01.007"},{"key":"3966_CR6","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1080\/10428194.2017.1298752","volume":"58","author":"C Nanni","year":"2017","unstructured":"Nanni C, Cottereau AS, Lopci E, Bodet-Milin C, Coronado M, Pro B, et al. Report of the 6th international workshop on PET in lymphoma. Leuk Lymphoma. 2017;58:2298\u2013303. \n                    https:\/\/doi.org\/10.1080\/10428194.2017.1298752\n                    \n                  .","journal-title":"Leuk Lymphoma"},{"key":"3966_CR7","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s00259-014-2822-7","volume":"41","author":"M Sasanelli","year":"2014","unstructured":"Sasanelli M, Meignan M, Haioun C, Berriolo-Riedinger A, Casasnovas RO, Biggi A, et al. Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma. Eur J Nucl Med Mol Imaging. 2014;41:2017\u201322. \n                    https:\/\/doi.org\/10.1007\/s00259-014-2822-7\n                    \n                  .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3966_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.2967\/jnumed.116.180406","volume":"58","author":"AS Cottereau","year":"2017","unstructured":"Cottereau AS, Hapdey S, Chartier L, Modzelewski R, Casasnovas O, Itti E, et al. Baseline total metabolic tumor volume measured with fixed or different adaptive thresholding methods equally predicts outcome in peripheral T cell lymphoma. J Nucl Med. 2017;58:276\u201381. \n                    https:\/\/doi.org\/10.2967\/jnumed.116.180406\n                    \n                  .","journal-title":"J Nucl Med"},{"key":"3966_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00259-017-3740-2","volume":"44","author":"N Aide","year":"2017","unstructured":"Aide N, Lasnon C, Veit-Haibach P, Sera T, Sattler B, Boellaard R. EANM\/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies. Eur J Nucl Med Mol Imaging. 2017;44:17\u201331. \n                    https:\/\/doi.org\/10.1007\/s00259-017-3740-2\n                    \n                  .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3966_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13550-017-0279-y","volume":"7","author":"C Lasnon","year":"2017","unstructured":"Lasnon C, Enilorac B, Popotte H, Aide N. Impact of the EARL harmonization program on automatic delineation of metabolic active tumour volumes (MATVs). EJNMMI Res. 2017;7:30. \n                    https:\/\/doi.org\/10.1186\/s13550-017-0279-y\n                    \n                  .","journal-title":"EJNMMI Res"},{"key":"3966_CR11","doi-asserted-by":"publisher","unstructured":"Toledano MN, Desbordes P, Banjar A, Gardin I, Vera P, Ruminy P, et al. Combination of baseline FDG PET\/CT total metabolic tumour volume and gene expression profile have a robust predictive value in patients with diffuse large B-cell lymphoma. Eur J Nucl Med Mol Imaging. 2018; \n                    https:\/\/doi.org\/10.1007\/s00259-017-3907-x\n                    \n                  .","DOI":"10.1007\/s00259-017-3907-x"},{"key":"3966_CR12","doi-asserted-by":"publisher","unstructured":"Oliveira FPM, Faria DB, Costa DC, Castelo-Branco M, Tavares JMRS. Extraction, selection and comparison of features for an effective automated computer-aided diagnosis of Parkinson\u2019s disease based on [123I]FP-CIT SPECT images. Eur J Nucl Med Mol Imaging. 2017; \n                    https:\/\/doi.org\/10.1007\/s00259-017-3918-7\n                    \n                  .","DOI":"10.1007\/s00259-017-3918-7"},{"key":"3966_CR13","doi-asserted-by":"publisher","unstructured":"Aide N, Talbot M, Fruchart C, Damaj G, Lasnon C. Diagnostic and prognostic value of baseline FDG PET\/CT skeletal textural features in diffuse large B cell lymphoma. Eur J Nucl Med Mol Imaging. 2017; \n                    https:\/\/doi.org\/10.1007\/s00259-017-3899-6\n                    \n                  .","DOI":"10.1007\/s00259-017-3899-6"},{"key":"3966_CR14","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1007\/s00259-016-3441-2","volume":"43","author":"C Lasnon","year":"2016","unstructured":"Lasnon C, Majdoub M, Lavigne B, Do P, Madelaine J, Visvikis D, et al. (18)F-FDG PET\/CT heterogeneity quantification through textural features in the era of harmonisation programs: a focus on lung cancer. Eur J Nucl Med Mol Imaging. 2016;43:2324\u201335. \n                    https:\/\/doi.org\/10.1007\/s00259-016-3441-2\n                    \n                  .","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-018-3966-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-3966-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-3966-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,16]],"date-time":"2019-02-16T22:31:17Z","timestamp":1550356277000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-018-3966-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,17]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["3966"],"URL":"https:\/\/doi.org\/10.1007\/s00259-018-3966-7","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,17]]},"assertion":[{"value":"22 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}